首页> 外文OA文献 >Appropriate Handling, Processing and Analysis of Blood Samples Is Essential to Avoid Oxidation of Vitamin C to Dehydroascorbic Acid
【2h】

Appropriate Handling, Processing and Analysis of Blood Samples Is Essential to Avoid Oxidation of Vitamin C to Dehydroascorbic Acid

机译:血液样品的适当处理,加工和分析对于避免维生素C氧化至脱氢血红酸是必不可少的

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Vitamin C (ascorbate) is the major water-soluble antioxidant in plasma and its oxidation to dehydroascorbic acid (DHA) has been proposed as a marker of oxidative stress in vivo. However, controversy exists in the literature around the amount of DHA detected in blood samples collected from various patient cohorts. In this study, we report on DHA concentrations in a selection of different clinical cohorts (diabetes, pneumonia, cancer, and critically ill). All clinical samples were collected into EDTA anticoagulant tubes and processed at 4 °C prior to storage at −80 °C for subsequent analysis by HPLC with electrochemical detection. We also investigated the effects of different handling and processing conditions on short-term and long-term ascorbate and DHA stability in vitro and in whole blood and plasma samples. These conditions included metal chelation, anticoagulants (EDTA and heparin), and processing temperatures (ice, 4 °C and room temperature). Analysis of our clinical cohorts indicated very low to negligible DHA concentrations. Samples exhibiting haemolysis contained significantly higher concentrations of DHA. Metal chelation inhibited oxidation of vitamin C in vitro, confirming the involvement of contaminating metal ions. Although EDTA is an effective metal chelator, complexes with transition metal ions are still redox active, thus its use as an anticoagulant can facilitate metal ion-dependent oxidation of vitamin C in whole blood and plasma. Handling and processing blood samples on ice (or at 4 °C) delayed oxidation of vitamin C by a number of hours. A review of the literature regarding DHA concentrations in clinical cohorts highlighted the fact that studies using colourimetric or fluorometric assays reported significantly higher concentrations of DHA compared to those using HPLC with electrochemical detection. In conclusion, careful handling and processing of samples, combined with appropriate analysis, is crucial for accurate determination of ascorbate and DHA in clinical samples.
机译:维生素C(抗坏血酸)是血浆中的主要的水溶性抗氧化剂和其氧化成脱氢抗坏血酸(DHA)已被提出作为在体内氧化应激的标志物。然而,争论在文献中存在围绕来自各种患者组采集的血液样品中的DHA的量进行检测。在这项研究中,我们在选择不同的临床同伙(糖尿病,肺炎,癌症和危重)对DHA浓度的报告。所有的临床样品收集到EDTA抗凝血剂管中并在4℃储存之前在-80℃下处理以用于随后的分析通过HPLC电化学检测。我们还研究了在体外对短期和长期的抗坏血酸和DHA稳定性和全血和血浆样品中的不同处理和加工条件的影响。这些包括金属螯合,抗凝血剂(EDTA和肝素)和加工温度(冰,4℃和室温)的条件。我们的临床队列分析表明非常低到可以忽略的DHA浓度。样品展示溶血包含显著较高浓度的DHA。金属螯合抑制维生素C体外氧化,确认污染金属离子的参与。虽然EDTA是一种有效的金属螯合剂,与过渡金属离子配合物仍然氧化还原活性,从而其作为抗凝血剂的使用可以促进维生素C在全血和血浆的金属离子依赖性的氧化。处理,并在冰上处理血液样品(或在4℃下)通过许多小时的延迟的维生素C的氧化。关于在临床同伙DHA浓度的文献综述强调,使用比色或荧光测定法研究报道显著较高浓度的DHA与使用HPLC带有电化学检测的那些事实。总之,小心处理和样品的处理,与适当的分析相结合,是临床样品中准确地测定抗坏血酸和DHA的关键。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号